Machine Learning-Based Peripheral Artery Disease Identification Using Laboratory-Based Gait Data

Peripheral artery disease (PAD) manifests from atherosclerosis, which limits blood flow to the legs and causes changes in muscle structure and function, and in gait performance. PAD is underdiagnosed, which delays treatment and worsens clinical outcomes. To overcome this challenge, the purpose of this study is to develop machine learning (ML) models that distinguish individuals with and without PAD. This is the first step to using ML to identify those with PAD risk early. We built ML models based on previously acquired overground walking biomechanics data from patients with PAD and healthy controls. Gait signatures were characterized using ankle, knee, and hip joint angles, torques, and powers, as well as ground reaction forces (GRF). ML was able to classify those with and without PAD using Neural Networks or Random Forest algorithms with 89% accuracy (0.64 Matthew’s Correlation Coefficient) using all laboratory-based gait variables. Moreover, models using only GRF variables provided up to 87% accuracy (0.64 Matthew’s Correlation Coefficient). These results indicate that ML models can classify those with and without PAD using gait signatures with acceptable performance. Results also show that an ML gait signature model that uses GRF features delivers the most informative data for PAD classification

Machine Learning-Based Peripheral Artery Disease Identification Using Laboratory-Based Gait Data

Peripheral artery disease (PAD) manifests from atherosclerosis, which limits blood flow to the legs and causes changes in muscle structure and function, and in gait performance. PAD is underdiagnosed, which delays treatment and worsens clinical outcomes. To overcome this challenge, the purpose of this study is to develop machine learning (ML) models that distinguish individuals with and without PAD. This is the first step to using ML to identify those with PAD risk early. We built ML models based on previously acquired overground walking biomechanics data from patients with PAD and healthy controls. Gait signatures were characterized using ankle, knee, and hip joint angles, torques, and powers, as well as ground reaction forces (GRF). ML was able to classify those with and without PAD using Neural Networks or Random Forest algorithms with 89% accuracy (0.64 Matthew’s Correlation Coefficient) using all laboratory-based gait variables. Moreover, models using only GRF variables provided up to 87% accuracy (0.64 Matthew’s Correlation Coefficient). These results indicate that ML models can classify those with and without PAD using gait signatures with acceptable performance. Results also show that an ML gait signature model that uses GRF features delivers the most informative data for PAD classification

Recent Advances in Machine Learning Applied to Ultrasound Imaging

Machine learning (ML) methods are pervading an increasing number of fields of application because of their capacity to effectively solve a wide variety of challenging problems. The employment of ML techniques in ultrasound imaging applications started several years ago but the scientific interest in this issue has increased exponentially in the last few years. The present work reviews the most recent (2019 onwards) implementations of machine learning techniques for two of the most popular ultrasound imaging fields, medical diagnostics and non-destructive evaluation. The former, which covers the major part of the review, was analyzed by classifying studies according to the human organ investigated and the methodology (e.g., detection, segmentation, and/or classification) adopted, while for the latter, some solutions to the detection/classification of material defects or particular patterns are reported. Finally, the main merits of machine learning that emerged from the study analysis are summarized and discussed. © 2022 by the authors. Licensee MDPI, Basel, Switzerland

Artificial Intelligence Application to Screen Abdominal Aortic Aneurysm Using Computed tomography Angiography

The aim of our study is to validate a totally automated deep learning (DL)-based segmentation pipeline to screen abdominal aortic aneurysms (AAA) in computed tomography angiography (CTA) scans. We retrospectively evaluated 73 thoraco-abdominal CTAs (48 AAA and 25 control CTA) by means of a DL-based segmentation pipeline built on a 2.5D convolutional neural network (CNN) architecture to segment lumen and thrombus of the aorta. The maximum aortic diameter of the abdominal tract was compared using a threshold value (30 mm). Blinded manual measurements from a radiologist were done in order to create a true comparison. The screening pipeline was tested on 48 patients with aneurysm and 25 without aneurysm. The average diameter manually measured was 51.1 ± 14.4 mm for patients with aneurysms and 21.7 ± 3.6 mm for patients without aneurysms. The pipeline correctly classified 47 AAA out of 48 and 24 control patients out of 25 with 97% accuracy, 98% sensitivity, and 96% specificity. The automated pipeline of aneurysm measurements in the abdominal tract reported a median error with regard to the maximum abdominal diameter measurement of 1.3 mm. Our approach allowed for the maximum diameter of 51.2 ± 14.3 mm in patients with aneurysm and 22.0 ± 4.0 mm in patients without an aneurysm. The DL-based screening for AAA is a feasible and accurate method, calling for further validation using a larger pool of diagnostic images towards its clinical use

Book of Abstracts 15th International Symposium on Computer Methods in Biomechanics and Biomedical Engineering and 3rd Conference on Imaging and Visualization

In this edition, the two events will run together as a single conference, highlighting the strong connection with the Taylor & Francis journals: Computer Methods in Biomechanics and Biomedical Engineering (John Middleton and Christopher Jacobs, Eds.) and Computer Methods in Biomechanics and Biomedical Engineering: Imaging and Visualization (JoãoManuel R.S. Tavares, Ed.). The conference has become a major international meeting on computational biomechanics, imaging andvisualization. In this edition, the main program includes 212 presentations. In addition, sixteen renowned researchers will give plenary keynotes, addressing current challenges in computational biomechanics and biomedical imaging. In Lisbon, for the first time, a session dedicated to award the winner of the Best Paper in CMBBE Journal will take place. We believe that CMBBE2018 will have a strong impact on the development of computational biomechanics and biomedical imaging and visualization, identifying emerging areas of research and promoting the collaboration and networking between participants. This impact is evidenced through the well-known research groups, commercial companies and scientific organizations, who continue to support and sponsor the CMBBE meeting series. In fact, the conference is enriched with five workshops on specific scientific topics and commercial software.info:eu-repo/semantics/draf

Contribuciones de las técnicas machine learning a la cardiología. Predicción de reestenosis tras implante de stent coronario

[ES]Antecedentes: Existen pocos temas de actualidad equiparables a la posibilidad de la tecnología actual para desarrollar las mismas capacidades que el ser humano, incluso en medicina. Esta capacidad de simular los procesos de inteligencia humana por parte de máquinas o sistemas informáticos es lo que conocemos hoy en día como inteligencia artificial. Uno de los campos de la inteligencia artificial con mayor aplicación a día de hoy en medicina es el de la predicción, recomendación o diagnóstico, donde se aplican las técnicas machine learning. Asimismo, existe un creciente interés en las técnicas de medicina de precisión, donde las técnicas machine learning pueden ofrecer atención médica individualizada a cada paciente. El intervencionismo coronario percutáneo (ICP) con stent se ha convertido en una práctica habitual en la revascularización de los vasos coronarios con enfermedad aterosclerótica obstructiva significativa. El ICP es asimismo patrón oro de tratamiento en pacientes con infarto agudo de miocardio; reduciendo las tasas de muerte e isquemia recurrente en comparación con el tratamiento médico. El éxito a largo plazo del procedimiento está limitado por la reestenosis del stent, un proceso patológico que provoca un estrechamiento arterial recurrente en el sitio de la ICP. Identificar qué pacientes harán reestenosis es un desafío clínico importante; ya que puede manifestarse como un nuevo infarto agudo de miocardio o forzar una nueva resvascularización del vaso afectado, y que en casos de reestenosis recurrente representa un reto terapéutico. Objetivos: Después de realizar una revisión de las técnicas de inteligencia artificial aplicadas a la medicina y con mayor profundidad, de las técnicas machine learning aplicadas a la cardiología, el objetivo principal de esta tesis doctoral ha sido desarrollar un modelo machine learning para predecir la aparición de reestenosis en pacientes con infarto agudo de miocardio sometidos a ICP con implante de un stent. Asimismo, han sido objetivos secundarios comparar el modelo desarrollado con machine learning con los scores clásicos de riesgo de reestenosis utilizados hasta la fecha; y desarrollar un software que permita trasladar esta contribución a la práctica clínica diaria de forma sencilla. Para desarrollar un modelo fácilmente aplicable, realizamos nuestras predicciones sin variables adicionales a las obtenidas en la práctica rutinaria. Material: El conjunto de datos, obtenido del ensayo GRACIA-3, consistió en 263 pacientes con características demográficas, clínicas y angiográficas; 23 de ellos presentaron reestenosis a los 12 meses después de la implantación del stent. Todos los desarrollos llevados a cabo se han hecho en Python y se ha utilizado computación en la nube, en concreto AWS (Amazon Web Services). Metodología: Se ha utilizado una metodología para trabajar con conjuntos de datos pequeños y no balanceados, siendo importante el esquema de validación cruzada anidada utilizado, así como la utilización de las curvas PR (precision-recall, exhaustividad-sensibilidad), además de las curvas ROC, para la interpretación de los modelos. Se han entrenado los algoritmos más habituales en la literatura para elegir el que mejor comportamiento ha presentado. Resultados: El modelo con mejores resultados ha sido el desarrollado con un clasificador extremely randomized trees; que superó significativamente (0,77; área bajo la curva ROC a los tres scores clínicos clásicos; PRESTO-1 (0,58), PRESTO-2 (0,58) y TLR (0,62). Las curvas exhaustividad sensibilidad ofrecieron una imagen más precisa del rendimiento del modelo extremely randomized trees que muestra un algoritmo eficiente (0,96) para no reestenosis, con alta exhaustividad y alta sensibilidad. Para un umbral considerado óptimo, de 1,000 pacientes sometidos a implante de stent, nuestro modelo machine learning predeciría correctamente 181 (18%) más casos en comparación con el mejor score de riesgo clásico (TLR). Las variables más importantes clasificadas según su contribución a las predicciones fueron diabetes, enfermedad coronaria en 2 ó más vasos, flujo TIMI post-ICP, plaquetas anormales, trombo post-ICP y colesterol anormal. Finalmente, se ha desarrollado una calculadora para trasladar el modelo a la práctica clínica. La calculadora permite estimar el riesgo individual de cada paciente y situarlo en una zona de riesgo, facilitando la toma de decisión al médico en cuanto al seguimiento adecuado para el mismo. Conclusiones: Aplicado inmediatamente después de la implantación del stent, un modelo machine learning diferencia mejor a aquellos pacientes que presentarán o no reestenosis respecto a los discriminadores clásicos actuales

Aerospace medicine and biology: A continuing bibliography with indexes (supplement 390)

This bibliography lists 102 reports, articles, and other documents introduced into the NASA Scientific and Technical Information System. Subject coverage includes: life sciences (general), aerospace medicine, behavioral sciences, man/system technology and life support, and space biology